1 completed, 1 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow Michael Iv: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI Diagnostic (ferumoxytol-enhanced MRI), Surgery, Ferumoxytol - Childhood Brain Neoplasm | Early Phase 1 | Withdrawn | Michael Iv | 2017-07-01 | 2023-04-14 | |
| Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS Ferumoxytol, Tissue Analysis, Magnetic Resonance Imaging - Brain Injury, Central Nervous System Degenerative Disorder | Early Phase 1 | Completed | Michael Iv | 10 | 2015-06-10 | 2017-08-31 |
Brain Injuries (1) · Brain Neoplasms (1) · Central Nervous System Infections (1) · Central Nervous System Vascular Malformations (1) · Hemorrhagic Stroke (1) · Ischemic Stroke (1) · Neurodegenerative Diseases (1)
Ferrosoferric Oxide (2) · Tissue Array Analysis (2) · Diagnosis (1) · Dynamic Contrast Enhanced Magnetic Resonance Imaging (1) · Magnetic Resonance Spectroscopy (1) · Surgical Procedures, Operative (1)
United States (1)
P30CA124435 (1)